David J. Chang

5.1k total citations · 1 hit paper
73 papers, 4.2k citations indexed

About

David J. Chang is a scholar working on Molecular Biology, Pharmacology and Rheumatology. According to data from OpenAlex, David J. Chang has authored 73 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 12 papers in Pharmacology and 12 papers in Rheumatology. Recurrent topics in David J. Chang's work include Inflammatory mediators and NSAID effects (12 papers), Systemic Lupus Erythematosus Research (10 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). David J. Chang is often cited by papers focused on Inflammatory mediators and NSAID effects (12 papers), Systemic Lupus Erythematosus Research (10 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). David J. Chang collaborates with scholars based in United States, United Kingdom and Australia. David J. Chang's co-authors include E K Morlok, Jeffrey R. Jasper, Nancy Fan, John M. Taylor, Kyung Bin Song, G M Ringold, Stephen Hall, Ronald Pedersen, Ferdinand C. Breedveld and Bruce Freundlich and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

David J. Chang

70 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial

2008 652 citations Paul Emery, Ferdinand C. Breedveld et al. The Lancet profile →

Peers

Countries citing papers authored by David J. Chang

Since Specialization

Citations

This map shows the geographic impact of David J. Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Chang more than expected).

Fields of papers citing papers by David J. Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Chang. The network helps show where David J. Chang may publish in the future.

Co-authorship network of co-authors of David J. Chang

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Chang. A scholar is included among the top collaborators of David J. Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Chang. David J. Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neonatal tooth infection resulting in subperiosteal orbital abscess: A case report 2020 ·International Journal of Pediatric Otorhinolaryngology ·(unknown), (unknown), (unknown), (unknown), (unknown), David J. Chang, Alexander P. Marston	3
2	Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA 2016 ·Lupus Science & Medicine ·Christopher Collins, Maria Dall’Era, H. Kan, Cynthia Macahilig, C. Molta, (unknown), David J. Chang	91
3	Ofatumumab, a fully human anti-CD20 monoclonal antibody, in biological-naive, rheumatoid arthritis patients with an inadequate response to methotrexate: a randomised, double-blind, placebo-controlled clinical trial 2011 ·Annals of the Rheumatic Diseases ·Peter C. Taylor, Emilia Quattrocchi, Stephen Mallett, Regina Kurrasch, Jørgen Holm Petersen, David J. Chang	90
4	Effects of Mandibular Retropositioning, With or Without Maxillary Advancement, on the Oro-Naso-Pharyngeal Airway and Development of Sleep-Related Breathing Disorders 2010 ·Journal of Oral and Maxillofacial Surgery ·(unknown), David J. Chang, (unknown), Maria B Papageorge	70
5	Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial breakdown → 2008 ·The Lancet ·Paul Emery, Ferdinand C. Breedveld, Stephen Hall, Patrick Durez, David J. Chang, Deborah Robertson, Amitabh Singh, Ronald Pedersen, Andrew Koenig, Bruce Freundlich	652
6	Remission rates in subjects with active early rheumatoid arthritis 1 year results of the COMET trial: Combination of methotrexate and etanercept in active early rheumatoid arthritis 2007 ·DIAL (Catholic University of Leuven) ·Paul Emery, Patrick Durez, Ferdinand C. Breedveld, Stephen Hall, Ronald Pedersen, Deborah Robertson, Bruce Freundlich, David J. Chang	5
7	Structure and Evolution of Human Apolipoprotein Genes: Identification of Regulatory Elements of the Human Apolipoprotein E Gene 2007 ·Novartis Foundation symposium ·(unknown), (unknown), Nabil A. Elshourbagy, Catherine A. Reardon, (unknown), David Walker, David J. Chang, Young‐Ki Paik	1
8	The Time to Onset and Overall Analgesic Efficacy of Rofecoxib 50 mg 2005 ·Clinical Journal of Pain ·Paul J. Desjardins, Donald R. Mehlisch, David J. Chang, David Krupa, Adam B. Polis, Richard A. Petruschke, Kerstin Malmström, Gregory P. Geba	13
9	The Analgesic Efficacy of Etoricoxib Compared with Oxycodone/Acetaminophen in an Acute Postoperative Pain Model: A Randomized, Double-Blind Clinical Trial 2004 ·Anesthesia & Analgesia ·David J. Chang, Paul J. Desjardins, Thomas King, Tara Erb, Gregory P. Geba	54
10	Comparison of rofecoxib and a multidose oxycodone/acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial 2004 ·Current Medical Research and Opinion ·David J. Chang, Paul J. Desjardins, Steven Bird, Peter M. Black, Erluo Chen, Richard A. Petruschke, Gregory P. Geba	25
11	A randomized controlled study comparing rofecoxib, diclofenac sodium, and placebo in post-bunionectomy pain 2004 ·Current Medical Research and Opinion ·Paul J. Desjardins, Peter M. Black, (unknown), Steven Bird, Brian Fitzgerald, Richard A. Petruschke, Andrew M. Tershakovec, David J. Chang	30
12	Discovery and SAR development of 2-(phenylamino) imidazolines as postacyclin receptor antagonists 2004 ·Bioorganic & Medicinal Chemistry Letters ·Robin D. Clark, Alam Jahangir, Daniel L. Severance, (unknown), Thomas K. H. Chang, David J. Chang, Mary Frances Jett, (unknown), Keith Bley	43
13	Extending transportation system capacity flexibility model 2003 ·The American Naturalist ·David J. Chang	1
14	Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: A randomized, placebo-controlled clinical trial 2002 ·Clinical Therapeutics ·David J. Chang, Paul J. Desjardins, Erluo Chen, Adam B. Polis, (unknown), (unknown), Gregory P. Geba	65
15	Comparison of Statistical Parametric Mapping and SPECT Difference Imaging in Patients with Temporal Lobe Epilepsy 2002 ·Epilepsia ·David J. Chang, I. George Zubal, (unknown), (unknown), Rik Stokking, Colin Studholme, (unknown), (unknown), (unknown), Hal Blumenfeld	80
16	Early Passive Mobilization after Digital Nerve Repair and Grafting in a Fresh Cadaver 2001 ·Plastic & Reconstructive Surgery ·(unknown), Stephan Alexander Braun, (unknown), J. Alexander Palesty, (unknown), Shamsuddin A. Syed, David J. Chang, J. Grant Thomson	16
17	The Cytoplasmic Domain of Human FcγRIa Alters the Functional Properties of the FcγRI·γ-Chain Receptor Complex 1999 ·Journal of Biological Chemistry ·Jeffrey C. Edberg, Arthur M.F. Yee, (unknown), David J. Chang, (unknown), Zena K. Indik, Alan D. Schreiber, Robert P. Kimberly	31
18	Human cloned α1A-adrenoceptor isoforms display α1L-adrenoceptor pharmacology in functional studies 1999 ·European Journal of Pharmacology ·Donald V. Daniels, Joel R. Gever, Jeffrey R. Jasper, (unknown), John Lesnick, (unknown), George Stepan, Timothy J. Williams, David E. Clarke, David J. Chang, Anthony Ford	68
19	The 5-HT7 receptor: orphan found 1997 ·Trends in Pharmacological Sciences ·Richard M. Eglen, Jeffrey R. Jasper, David J. Chang, Graeme R. Martin	146
20	Dapsone in rheumatoid arthritis 1996 ·Seminars in Arthritis and Rheumatism ·David J. Chang, (unknown), (unknown), Leonard H. Sigal	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact